Listar Investigación y Desarrollo por autor "Cano, Amanda"
Mostrando ítems 1-6 de 6
-
Article
A novel rhein-huprine hybrid ameliorates disease-modifying properties in preclinical mice model of Alzheimer’s disease exacerbated with high fat diet (2024)
Espinosa-Jiménez, Triana; Cano, Amanda; Sánchez-López, Elena; Olloquequi, Jordi; Folch, Jaume; Bulló, Mònica; Verdaguer, Ester; Auladell, Carme; Pont, Caterina; Muñoz-Torrero, Diego; ... (BioMed Central Ltd, 2023)Background: Alzheimer’s disease (AD) is characterized by a polyetiological origin. Despite the global burden of AD and the advances made in AD drug research and development, the cure of the disease remains elusive, since ... -
Article
Dexibuprofen ameliorates peripheral and central risk factors associated with Alzheimer’s disease in metabolically stressed APPswe/PS1dE9 mice (2021)
Ettcheto, Miren; Sánchez-López, Elena; Cano, Amanda; Carrasco, Marina; Herrera, Katherine; Manzine, Patricia Regina; Espinosa-Jiménez, Triana; Busquets, Oriol; Verdaguer, Ester; Olloquequi, Jordi; ... (BioMed Central Ltd, 2021-12)Background: Several studies stablished a relationship between metabolic disturbances and Alzheimer´s disease (AD) where inflammation plays a pivotal role. However, mechanisms involved still remain unclear. In the present ... -
Article
Impact of New Drugs for Therapeutic Intervention in Alzheimer’s Disease (2024)
Olloquequi, Jordi; Ettcheto, Miren; Cano, Amanda; Sanchez-López, Elena; Carrasco, Marina; Espinosa, Triana; Beas-Zarate, Carlos; Gudiño-Cabrera, Graciela; Ureña-Guerrero, Monica E.; Verdaguer, Ester; ... (Bioscience Research Institute, 2022)The increases in population ageing and growth are leading to a boosting in the number of people living with dementia, Alzheimer’s disease (AD) being the most common cause. In spite of decades of intensive research, no cure ... -
Article
Licochalcone A: A Potential Multitarget Drug for Alzheimer’s Disease Treatment (2024)
Olloquequi, Jordi; Ettcheto, Miren; Cano, Amanda; Fortuna, Ana; Bicker, Joana; Sánchez-Lopez, Elena; Paz, Cristian; Ureña, Jesús; Verdaguer, Ester; Auladell, Carme; ... (Multidisciplinary Digital Publishing Institute (MDPI), 2023)Licochalcone A (Lico-A) is a flavonoid compound derived from the root of the Glycyrrhiza species, a plant commonly used in traditional Chinese medicine. While the Glycyrrhiza species has shown promise in treating various ... -
Article
Metformin a potential pharmacological strategy in late onset Alzheimer’s disease treatment (2021)
Poor, Saghar Rabiei; Ettcheto, Miren; Cano, Amanda; Sánchez-López, Elena; Manzine, Patricia Regina; Olloquequi, Jordi; Camins, Antoni; Javan, Mohammad (MDPI, 2021-09)Alzheimer’s disease (AD) is one of the most devastating brain disorders. Currently, there are no effective treatments to stop the disease progression and it is becoming a major public health concern. Several risk factors ... -
Article
Protein tyrosine phosphatase 1B (PTP1B) as a potential therapeutic target for neurological disorders (2024)
Olloquequi, Jordi; Cano, Amanda; Sanchez-López, Elena; Carrasco, Marina; Verdaguer, Ester; Fortuna, Ana; Folch, Jaume; Bulló, Mònica; Auladell, Carme; Camins, Antoni; ... (Elsevier Masson s.r.l., 2022)Protein tyrosine phosphatase 1B (PTP1B) is a typical member of the PTP family, considered a direct negative regulator of several receptor and receptor-associated tyrosine kinases. This widely localized enzyme has been ...